Inovio Pharmaceuticals, Inc.
OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTS
Last updated:
Abstract:
Disclosed herein are compositions comprising structurally modified DNA encoded antibodies (DMAbs), methods of structurally modifying DMAbs, and methods of using structurally modified DMAbs.
Status:
Application
Type:
Utility
Filling date:
10 May 2018
Issue date:
24 Jun 2021